Brian Thomas
Net worth: 3 M $ as of 31/08/2026
Net worth: 3 M $ as of 31/08/2026
Brian C.
Thomas was the founder of Metagenomi Technologies LLC, founded in 2016, where the title held was Chief Executive Officer & Director.
Dr. Thomas was the founder of Metagenomi Therapeutics, Inc., founded in 2016, where the title held was Director from 2025 to 2026.
Dr. Thomas currently holds the position of Chairman at HAYA Therapeutics SA since 2022.
Formerly, Dr. Thomas was a Program Manager at Berkeley University of California from 2001 to 2017.
Dr. Thomas completed undergraduate and doctorate degrees at the University of Kansas.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/06/2026 | 2,433,969 ( 6.44% ) | 3 M $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology Develops RNA-based therapeutics to treating fibrotic diseases | Chairman | 01/12/2022 |
| Companies | Position | End |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Chief Executive Officer | - |
Berkeley University of California
Berkeley University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2017 |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology Develops RNA-based therapeutics to treating fibrotic diseases | Health Technology |
Metagenomi, Inc.
Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Berkeley University of California
Berkeley University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions